154 related articles for article (PubMed ID: 18585009)
1. Neurodevelopmental markers in different psychopathological dimensions of first episode psychosis: the ESPIGAS study.
Ruiz-Veguilla M; Cervilla JA; Barrigón ML; Ferrín M; Gutiérrez B; Gordo E; Anguita M; Brañas A; Fernández-Logroño J; Gurpegui M
Eur Psychiatry; 2008 Dec; 23(8):533-40. PubMed ID: 18585009
[TBL] [Abstract][Full Text] [Related]
2. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
3. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
[TBL] [Abstract][Full Text] [Related]
4. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena.
Whitty P; Clarke M; Browne S; McTigue O; Kamali M; Feeney L; Lane A; Kinsella A; Waddington JL; Larkin C; O'Callaghan E
Psychol Med; 2003 Nov; 33(8):1479-84. PubMed ID: 14672257
[TBL] [Abstract][Full Text] [Related]
6. [Neurological soft signs in early onset schizophrenia].
Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
[TBL] [Abstract][Full Text] [Related]
7. Predictors of 10-year outcome of first-episode psychosis.
White C; Stirling J; Hopkins R; Morris J; Montague L; Tantam D; Lewis S
Psychol Med; 2009 Sep; 39(9):1447-56. PubMed ID: 19187566
[TBL] [Abstract][Full Text] [Related]
8. Hard neurologic signs and psychopathology in relatives of schizophrenic patients.
Kinney DK; Yurgelun-Todd DA; Woods BT
Psychiatry Res; 1991 Oct; 39(1):45-53. PubMed ID: 1771208
[TBL] [Abstract][Full Text] [Related]
9. The Nithsdale Schizophrenia Surveys. XII. 'Neurodevelopmental' Schizophrenia: a search for clinical correlates and putative aetiological factors.
McCreadie RG; Connolly MA; Williamson DJ; Athawes RW; Tilak-Singh D
Br J Psychiatry; 1994 Sep; 165(3):340-6. PubMed ID: 7994503
[TBL] [Abstract][Full Text] [Related]
10. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
[TBL] [Abstract][Full Text] [Related]
11. Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?
Tamagni C; Studerus E; Gschwandtner U; Aston J; Borgwardt S; Riecher-Rössler A
Psychiatry Res; 2013 Dec; 210(2):427-31. PubMed ID: 23880482
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
13. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
John JP; Khanna S; Thennarasu K; Reddy S
Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
[TBL] [Abstract][Full Text] [Related]
14. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
[TBL] [Abstract][Full Text] [Related]
15. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial functioning in first-episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms.
Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
Early Interv Psychiatry; 2017 Feb; 11(1):23-36. PubMed ID: 25585960
[TBL] [Abstract][Full Text] [Related]
17. Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis.
Jones PB; Harvey I; Lewis SW; Toone BK; Van Os J; Williams M; Murray RM
Psychol Med; 1994 Nov; 24(4):995-1011. PubMed ID: 7892367
[TBL] [Abstract][Full Text] [Related]
18. The dimensionality of schizophrenia concepts in first-episode psychosis.
Bell RC; Dudgeon P; McGorry PD; Jackson HJ
Acta Psychiatr Scand; 1998 May; 97(5):334-42. PubMed ID: 9611083
[TBL] [Abstract][Full Text] [Related]
19. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
Moukas G; Stathopoulou A; Gourzis P; Beratis IN; Beratis S
Compr Psychiatry; 2010; 51(1):1-7. PubMed ID: 19932819
[TBL] [Abstract][Full Text] [Related]
20. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.
Dominguez Mde G; Viechtbauer W; Simons CJ; van Os J; Krabbendam L
Psychol Bull; 2009 Jan; 135(1):157-71. PubMed ID: 19210058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
